DE69927039D1 - Synthetische analoge des ecteinascidin-743 - Google Patents
Synthetische analoge des ecteinascidin-743Info
- Publication number
- DE69927039D1 DE69927039D1 DE69927039T DE69927039T DE69927039D1 DE 69927039 D1 DE69927039 D1 DE 69927039D1 DE 69927039 T DE69927039 T DE 69927039T DE 69927039 T DE69927039 T DE 69927039T DE 69927039 D1 DE69927039 D1 DE 69927039D1
- Authority
- DE
- Germany
- Prior art keywords
- substituted
- unsubstituted
- co2h
- nhc
- alkynyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/165,892 US6124292A (en) | 1998-09-30 | 1998-09-30 | Synthetic analogs of ecteinascidin-743 |
US165892 | 1998-09-30 | ||
PCT/US1999/022405 WO2000018233A1 (en) | 1998-09-30 | 1999-09-30 | Synthetic analogs of ecteinascidin-743 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69927039D1 true DE69927039D1 (de) | 2005-10-06 |
DE69927039T2 DE69927039T2 (de) | 2006-06-22 |
Family
ID=22600906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69927039T Expired - Lifetime DE69927039T2 (de) | 1998-09-30 | 1999-09-30 | Synthetische analoge des ecteinascidin-743 |
Country Status (13)
Country | Link |
---|---|
US (3) | US6124292A (de) |
EP (1) | EP1117297B1 (de) |
JP (1) | JP4638985B2 (de) |
AT (1) | ATE303063T1 (de) |
AU (1) | AU765439B2 (de) |
CA (1) | CA2345297C (de) |
DE (1) | DE69927039T2 (de) |
DK (1) | DK1117297T3 (de) |
ES (1) | ES2249028T3 (de) |
HK (1) | HK1039727B (de) |
MX (1) | MXPA01003339A (de) |
NZ (1) | NZ510734A (de) |
WO (1) | WO2000018233A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2239442T3 (es) * | 1998-05-11 | 2005-09-16 | Pharma Mar, S.A. | Metabolitos de ecteinascidina 743. |
US6124292A (en) * | 1998-09-30 | 2000-09-26 | President And Fellows Of Harvard College | Synthetic analogs of ecteinascidin-743 |
MY164077A (en) * | 1999-05-13 | 2017-11-30 | Pharma Mar Sa | Compositions and uses of et743 for treating cancer |
MY130271A (en) * | 1999-05-14 | 2007-06-29 | Pharma Mar Sa | Hemisynthetic method and new compounds |
GB9918178D0 (en) * | 2000-05-15 | 1999-10-06 | Pharma Mar Sa | Synthetic methods |
CA2397597A1 (en) | 2000-01-19 | 2001-07-26 | The Trustees Of Columbia University In The City Of New York | Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
US6815544B2 (en) | 2000-02-11 | 2004-11-09 | President And Fellows Of Harvard College | Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds |
RU2267492C2 (ru) * | 2000-02-11 | 2006-01-10 | Президент Энд Феллоуз Оф Гарвард Колледж | Способ синтеза фталасцидина и промежуточных продуктов и промежуточные соединения |
US7919493B2 (en) * | 2000-04-12 | 2011-04-05 | Pharma Mar, S.A. | Anititumoral ecteinascidin derivatives |
PT1280809E (pt) * | 2000-04-12 | 2005-11-30 | Pharma Mar Sa | Derivados antitumorais de ecteinascidina |
US7420051B2 (en) * | 2000-05-15 | 2008-09-02 | Pharma Mar, S.A. | Synthetic process for the manufacture of an ecteinaschidin compound |
MXPA02011319A (es) * | 2000-05-15 | 2003-06-06 | Pharma Mar Sa | Analogos antitumorales de ecteinascidina 743. |
US6809099B2 (en) | 2000-11-03 | 2004-10-26 | President And Fellows Of Harvard College | Saframycins, analogues and uses thereof |
CZ20031327A3 (cs) * | 2000-11-06 | 2003-11-12 | Pharma Mar, S. A. | Užití ET-743 k výrobě léků pro účinnou protinádorovou léčbu |
GB0117402D0 (en) * | 2001-07-17 | 2001-09-05 | Pharma Mar Sa | New antitumoral derivatives of et-743 |
GB0119243D0 (en) * | 2001-08-07 | 2001-10-03 | Pharma Mar Sa | Antitumoral analogs of ET-743 |
GB0202544D0 (en) * | 2002-02-04 | 2002-03-20 | Pharma Mar Sa | The synthesis of naturally occuring ecteinascidins and related compounds |
US7183054B2 (en) * | 2003-06-03 | 2007-02-27 | President And Fellows Of Harvard College | Assay for identifying biological targets of polynucleotide-binding compounds |
SI1827500T1 (sl) * | 2004-10-26 | 2009-10-31 | Pharma Mar Sa | Pegiliran liposomski doksorubicin v kombinaciji s ekteinescidinom 743 |
SI1658848T1 (sl) | 2004-10-29 | 2007-12-31 | Pharma Mar Sa | Formulacije vsebujoäśe ekteinascidin in disaharid |
GB0522082D0 (en) * | 2005-10-31 | 2005-12-07 | Pharma Mar Sa | Formulations |
JP2011520921A (ja) * | 2008-05-16 | 2011-07-21 | ファルマ・マール・ソシエダード・アノニマ | 抗腫瘍アルカロイドとの併用療法 |
KR20110028454A (ko) * | 2008-05-16 | 2011-03-18 | 파르마 마르 에스.에이. | 다발성 골수종 치료법 |
WO2011048210A1 (en) | 2009-10-22 | 2011-04-28 | Pharma Mar, S.A. | PDGFR-α AS RESPONSE MARKER FOR PM00104 TREATMENT |
US9428524B2 (en) | 2010-05-25 | 2016-08-30 | Pharma Mar, S.A. | Synthetic process for the manufacture of ecteinascidin compounds |
RS54648B1 (en) | 2010-11-12 | 2016-08-31 | Pharma Mar S.A. | COMBINED THERAPY WITH ANTITUMOR ALKALOID |
CN107522698B (zh) * | 2016-06-20 | 2021-12-28 | 浙江海正药业股份有限公司 | 一种曲贝替定的制备方法及其中间体 |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
US10597378B2 (en) | 2017-09-08 | 2020-03-24 | National Health Research Institutes | Tetrahydroisoquinolines for use as MOR/NOP dual agonists |
CN111518110B (zh) * | 2019-02-01 | 2023-11-03 | 博瑞生物医药(苏州)股份有限公司 | 一种海鞘素化合物及其中间体的制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5937952B2 (ja) | 1977-09-12 | 1984-09-12 | 正 新井 | 抗生物質サフラマイシンa,b,c,d,eおよびその製造法 |
JPS56135486A (en) | 1980-03-26 | 1981-10-22 | Tadashi Arai | Antibiotic saframycin s and its preparative method |
JPS5942382A (ja) * | 1982-09-02 | 1984-03-08 | Yoshitomi Pharmaceut Ind Ltd | サフラシン誘導体 |
JPS6158593A (ja) * | 1984-08-30 | 1986-03-25 | Tadashi Arai | 新規サフラマイシンa誘導体およびその製造法 |
EP0233841A1 (de) * | 1986-02-18 | 1987-08-26 | Arai, Tadashi, Prof. | Chinon-Derivate und Verfahren zu ihrer Herstellung |
US5089273A (en) * | 1986-06-09 | 1992-02-18 | Board Of Trustees Of The University Of Illinois | Ecteinascidins 729, 743, 745, 759A, 759B and 770 |
US5256663A (en) * | 1986-06-09 | 1993-10-26 | The Board Of Trustees Of The University Of Illinois | Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith |
JPS632991A (ja) * | 1986-06-23 | 1988-01-07 | Akinori Kubo | 新規イソキノリン誘導体 |
EP0262085A1 (de) * | 1986-08-15 | 1988-03-30 | Gesellschaft für Biotechnologische Forschung mbH (GBF) | Antibiotika aus Myxococcus |
EP0329606A3 (de) * | 1988-02-12 | 1991-04-03 | Ciba-Geigy Ag | Neue Antibiotika aus Myxococcus |
US5478932A (en) * | 1993-12-02 | 1995-12-26 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins |
US5721362A (en) * | 1996-09-18 | 1998-02-24 | President And Fellows Of Harvard College | Process for producing ecteinascidin compounds |
US6124292A (en) * | 1998-09-30 | 2000-09-26 | President And Fellows Of Harvard College | Synthetic analogs of ecteinascidin-743 |
-
1998
- 1998-09-30 US US09/165,892 patent/US6124292A/en not_active Expired - Lifetime
-
1999
- 1999-09-30 JP JP2000571761A patent/JP4638985B2/ja not_active Expired - Lifetime
- 1999-09-30 AU AU61650/99A patent/AU765439B2/en not_active Expired
- 1999-09-30 DK DK99948484T patent/DK1117297T3/da active
- 1999-09-30 EP EP99948484A patent/EP1117297B1/de not_active Expired - Lifetime
- 1999-09-30 NZ NZ510734A patent/NZ510734A/en not_active IP Right Cessation
- 1999-09-30 ES ES99948484T patent/ES2249028T3/es not_active Expired - Lifetime
- 1999-09-30 DE DE69927039T patent/DE69927039T2/de not_active Expired - Lifetime
- 1999-09-30 AT AT99948484T patent/ATE303063T1/de active
- 1999-09-30 WO PCT/US1999/022405 patent/WO2000018233A1/en active IP Right Grant
- 1999-09-30 CA CA002345297A patent/CA2345297C/en not_active Expired - Lifetime
- 1999-09-30 MX MXPA01003339A patent/MXPA01003339A/es active IP Right Grant
-
2000
- 2000-02-22 US US09/510,315 patent/US6348467B1/en not_active Ceased
-
2002
- 2002-01-24 HK HK02100545.8A patent/HK1039727B/zh not_active IP Right Cessation
-
2003
- 2003-12-17 US US10/738,973 patent/USRE41614E1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1117297B1 (de) | 2005-08-31 |
HK1039727A1 (en) | 2002-05-10 |
EP1117297A4 (de) | 2002-02-27 |
ATE303063T1 (de) | 2005-09-15 |
JP4638985B2 (ja) | 2011-02-23 |
DE69927039T2 (de) | 2006-06-22 |
DK1117297T3 (da) | 2006-01-09 |
US6124292A (en) | 2000-09-26 |
USRE41614E1 (en) | 2010-08-31 |
CA2345297C (en) | 2009-12-22 |
AU765439B2 (en) | 2003-09-18 |
WO2000018233A1 (en) | 2000-04-06 |
JP2002525296A (ja) | 2002-08-13 |
EP1117297A1 (de) | 2001-07-25 |
CA2345297A1 (en) | 2000-04-06 |
HK1039727B (zh) | 2006-01-06 |
AU6165099A (en) | 2000-04-17 |
NZ510734A (en) | 2003-10-31 |
US6348467B1 (en) | 2002-02-19 |
MXPA01003339A (es) | 2002-07-02 |
ES2249028T3 (es) | 2006-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69927039D1 (de) | Synthetische analoge des ecteinascidin-743 | |
DE60033857D1 (de) | Derivate des N-((Chinolinyl)oxy)-phenyl)-Harnstoffs und des N-((Chinazolinyl)oxy)-phenyl)-Harnstoffs mit Antitumor Aktivität | |
MXPA04001240A (es) | Analogos antitumorales. | |
EA200600509A1 (ru) | Соединения пиримидотиофена | |
CY1109283T1 (el) | Παραγωγα βαριολινης ως αντικαρκινικα μεσα | |
CY1113359T1 (el) | Αντι-νεοπλασιακα παραγωγα του et-743 | |
ATE118207T1 (de) | Heterozyklische acylaminodiol-beta-aminosäure- derivate. | |
DE60237652D1 (de) | Variolinderivate und ihre Verwendung als Cytostatika | |
MXPA02012121A (es) | Compuestos antitumorales. | |
BR9709791A (pt) | Intermediários para a síntese de oligonucleotíedeos | |
DE60116855D1 (de) | Oxy- und aminosubstituierte tetrahydrofurylderivate mit antitumoraktivität | |
NO20051037L (no) | Totalsyntese av myriaporoner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |